Filter
News & Insights
- Pricing & Contracting
eBook: Medicaid Drug Rebate Program Summit Post-Event Report 2023
Read More - Pricing & Contracting
Webcast: The State of National Healthcare Policy and Pricing 2023
Read More - Pricing & Contracting
Post-Webinar Recap and Q&A with Stephanie Kupski
Read More - Cell & Gene TherapyPricing & Contracting
The challenges in reimbursement for cell and gene therapies
Read More - Pricing & Contracting
Federal and State Drug Pricing Regulation: What Laws and Changes Do We Anticipate in the Next 6-12 Months?
Read More - Pricing & Contracting
State Price Transparency Reporting (SPTR): Laws, Experience, Outlook, From Legal and Operational Perspectives | ClassOne Insight and Arent Fox
Read More - Pricing & Contracting
340B: Living with the Adolescent Colossus | King & Spalding
Read More - Pricing & Contracting
"We should be on the lookout for the possible return of a Most Favored Nation reference pricing scheme" - Q&A with Katherine Chaurette, Blueprint Medicines
Read More - Pricing & Contracting
"There is always something interesting behind a state's motivation to control prescription drug costs" - Q&A with Porzio Life Sciences
Read More - Talent, Diversity & Inclusion, Life SciencesCell & Gene TherapyAccess & Channel
REPORT: COVID-19 One Year On - Impacts on the Global Life Sciences Industry 2021
Read More - Access & ChannelPricing & Contracting
What does it mean to be patient centered in health economics?
Read More - Pricing & Contracting
The evolution and challenges of State Price Transparency Reporting laws | Al Godley, ClassOne Insight
Read More - Pricing & Contracting
"Contracting will be the biggest innovation, but how it is actually implemented will be a challenge" - Cathy Burton-Meza, Gilead
Read More - Pricing & Contracting
"I see the very real possibility of value based contracting becoming more mainstream for drug manufacturers"
Read More - Talent, Diversity & Inclusion, Life SciencesCell & Gene TherapyAccess & Channel
SURVEY: Diversity, Equity and Inclusion in the Life Sciences 2021
Read More - Access & ChannelHealthcare InsurancePricing & Contracting
Pricing & Reimbursement US 2020
Read More - Accounting & Financial ReportingPricing & Contracting
The 340B Drug Discount Program: Complexity, Challenges, and Change
Read More - Cell & Gene TherapyClinical & Medical AffairsBioprocessing & Manufacturing
Pharma’s role in maintaining cancer mortality progress during COVID-19
Read More - Pricing & Contracting
Modeling SDOH financial sustainability
Read More - Bioprocessing & ManufacturingPricing & ContractingPartnering, Business Development & Licensing
Driving value in the era of biosimilars - What payers & manufacturers can do to support employers
Read More